Skip to main content
RNAC $9.20 -4.17%
RNAC logo
RNAC · Cartesian Therapeutics, Inc.
Track RNAC — free
$9.20 -0.40 (-4.17%)
Market Cap
$290.45M
Shares
30.26M
All earnings calls

Earnings call · FY2020 Q4

Cartesian Therapeutics, Inc. (RNAC) Q4 2020 Earnings Call

Concluded Mar 11, 2021
Mar 11, 2021 0 turns
Period
FY2020 Q4
Runtime
Sources
2 artifacts

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. 8-K earnings release, 10-K stay in one workspace.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Revenue · derived Q4 $11.95M +79.6% YoY
Net income · derived Q4 -$15.45M

Research materials

Open the source you need; every reader stays inside this workspace.

Full-screen source Call document